Overview

Fragmin In The Treatment Of Acute Deep-Vein Thrombosis With Or Without Pulmonary Embolism In Cancer Patients

Status:
Completed
Trial end date:
2009-06-01
Target enrollment:
Participant gender:
Summary
To collect postmarketing data about Fragmin safety and efficacy in the treatment of deep vein thrombosis with or without pulmonary embolism in cancer patients.
Details
Lead Sponsor:
Pfizer
Treatments:
Dalteparin
Heparin, Low-Molecular-Weight
Tinzaparin